PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Neonatal abstinence syndrome (NAS) is a group of problems that occur in a newborn who was exposed to addictive illegal or prescription drugs while in the mother’s womb. Babies of mothers who drink during pregnancy may have a similar condition.
Causes, incidence, and risk factors
Neonatal abstinence syndrome occurs because a pregnant woman takes addictive illicit or prescription drugs such as:
- Amphetamines
- Barbiturates
- Benzodiazepines (diazepam, clonazepam)
- Cocaine
- Marijuana
- Opiates/Narcotics (heroin, methadone, codeine)
These and other substances pass through the placenta to the baby during pregnancy. The placenta is the organ that connects the baby to its mother in the womb. The baby becomes addicted along with the mother.
At birth, the baby is still dependent on the drug. Because the baby is no longer getting the drug after birth, symptoms of withdrawal may occur.
Alcohol use during pregnancy can also cause problems in the baby. See: Fetal alcohol syndrome
Symptoms
The symptoms of neonatal abstinence syndrome depend on:
- The type of drug the mother used
- How the mother's body breaksdown the drug
- How much of the drug she was taking
- How long she used the drug
- Whether the baby was born full-term or early (premature)
Symptoms depend on the drug involved. They can begin within 1 - 3 days after birth, or they may take 5 - 10 days to appear. They may include:
- Blotchy skin coloring (mottling)
- Diarrhea
- Excessive crying or high-pitched crying
- Excessive sucking
- Fever
- Hyperactive reflexes
- Increased muscle tone
- Irritability
- Poor feeding
- Rapid breathing
- Seizures
- Sleep problems
- Slow weight gain
- Stuffy nose, sneezing
- Sweating
- Trembling (tremors)
- Vomiting
Signs and tests
It is important to have your baby checked out by a pediatrician. Many other conditions can produce the same symptoms as neonatal abstinence syndrome.
The doctor will ask questions about the mother's drug use, such as what drugs she took during pregnancy, and when she last took them.
Tests that may be done to diagnose withdrawal in a newborn include:
- Neonatal abstinence syndrome scoring system, which assigns points based on each symptom and its severity. The infant’s score can help determine treatment.
- Toxicology screen of first bowel movements (meconium)
- Urine test (urinalysis)
Treatment
Treatment depends on:
- The drug involved
- The infant’s overall health
- Whether the baby was born full-term or premature
The health care team will watch the newborn carefully for signs of withdrawal, feeding problems, and weight gain. Babies who vomit or who are very dehydrated may need to get fluids through a vein (intravenously).
Infants with neonatal abstinence syndrome are often fussy and hard to calm. Tips to calm the infant down include:
- Gently rocking the child
- Reducing noise and lights
- Swaddling the baby in a blanket
Some babies with severe symptoms need medicine to treat withdrawal symptoms. Medicines may include:
The doctor may prescribe the infant a drug similar to the one the mother used during pregnancy and slowly decrease the dose over time. This helps wean the baby off the drug and relieve some withdrawal symptoms. Breastfeeding may also be helpful.
Babies with this condition often have poor feeding or slow growth. Such babies may need:
- A higher-calorie formula that provides greater nutrition
- Smaller portions given more often
Expectations (prognosis)
Treatment helps relieve symptoms of withdrawal.
Complications
Drug and alcohol use during pregnancy can lead to many health problems in the baby, including:
- Birth defects
- Low birth weight
- Premature birth
- Small head circumference
- Sudden infant death syndrome (SIDS)
Neonatal abstinence syndrome can last from 1 week to 6 months.
Calling your health care provider
Make sure your doctor or nurse know about all the drugs you take during pregnancy.
Call your doctor or nurse if your baby has symptoms of neonatal abstinence syndrome.
Prevention
Discuss all medications, alcohol and tobacco with your health care provider. If you are using drugs, including alcohol or tobacco, ask your health care provider for help with stopping as soon as possible. If you are already pregnant, talk to your health care provider about the best way to stop using and keep yourself and the baby safe.
References
- Wong S, Ordean A, Kahan M; Maternal Fetal Medicine Committee; Family Physicians Advisory Committee; Medico-Legal Committee; Society of Obstetricians and Gynaecologists of Canada. Substance use in pregnancy. J Obstet Gynaecol Can. 2011 Apr;33(4):367-84. [PubMed: 21501542]
- Jansson LM, Velez M. Neonatal abstinence syndrome. Curr Opin Pediatr. 2012 Jan 5. [Epub ahead of print] [PubMed: 22227786]
- Bio LL, Siu A, Poon CY. Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol. 2011 Nov;31(11):692-701. . [PubMed: 21869765]
- McQueen KA, Murphy-Oikonen J, Gerlach K, Montelpare W.The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care. 2011 Aug;11(4):282-90. [PubMed: 22123351]
- Cornelius MD, Day NL..Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol. 2009 Apr;22(2):121-5. [PMC free article: PMC2745235] [PubMed: 19532034]
- Keegan J, Parva M, Finnegan M, Gerson A, Belden M.Addiction in pregnancy. J Addict Dis. 2010 Apr;29(2):175-91. [PubMed: 20407975]
Review Date: 1/27/2012.
Reviewed by: Kimberly G Lee, MD, MSc, IBCLC, Associate Professor of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, SC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Mantenance agonist tratments for opiate dependent pregnant women.
Some women continue to use opiates when they are pregnant. Yet heroin readily crosses the placenta. Opiate dependent women experience a six‐fold increase in maternal obstetric complications and give birth to low‐weight babies. The newborn may experience narcotic withdrawal (neonatal abstinence syndrome), have development problems, increased neonatal mortality and a 74‐fold increased risk of sudden infant death syndrome. Maintenance treatment with methadone provides a steady concentration of opiate in the pregnant woman's blood and so prevents the adverse effects on the fetus of repeated withdrawals. Buprenorphine is also used. They reduce illicit drug use, improve compliance with obstetric care and improve birth weight but are still associated with neonatal abstinence syndrome. The present review found few differences in newborn or maternal outcomes for pregnant opiate‐addicted women who were maintained on methadone, buprenorphine or oral slow morphine from a mean gestational age of 23 weeks to delivery. Only three randomised controlled trials satisfied the criteria for the review, two from Austria (outpatients) and one from the USA (inpatients). The trials continued for 15 to 18 weeks. Two compared methadone with buprenorphine (48 participants) and one compared methadone with oral slow morphine (48 participants). The number of women who dropped out from treatment and the use of primary substance appeared to be the same for methadone and buprenorphine. Oral slow morphine seemed superior to methadone for the number of women who used heroin in their third trimester but without a clear improvement in infant birth weight or duration of neonatal abstinence syndrome.The number of participants in the trials was very small and may not be sufficient to detect differences. Only one study reported on the number of cigarettes the women smoked, a mean of 29 cigarettes per day at enrolment and 14 cigarettes per day at delivery. All the included studies ended immediately after the baby was born. No severe complications were noted.
The science behind screening testsScreening tests can lead to benefits and harms. Understand why, and how researchers find out if benefits outweigh harms for a test.
- Neonatal abstinence syndromeNeonatal abstinence syndromePubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...